NASDAQ · SERVICES-MEDICAL LABORATORIES · MID CAP
Fortrea Holdings Inc. FTRE
5 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$2.7B
▲ 1.0% vs FY2024
EPS · FY25
$-10.81
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
-102.4%
Net margin · FY25
-36.2%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 2.7B
Revenue, FY2025 · full 5-year series below
Revenue
Net income
The company lost 36 cents on every revenue dollar this year.
Per share
USD -10.81
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
-102.4%
Return on equity, FY2025
ROE
Operating margin-32.0%
Net margin-36.2%
Return on assets-31.3%
Each USD of equity lost 102 cents this year.
Returned to shareholders
—
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—
Growth
—
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
−1.4%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.09B
Shares outstanding, FY2025
Change, 5 years—
Change, 10 years—
A share split breaks the comparison across the period, so we leave it out.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 2.7B
total assets, end of FY2025
Total assetsUSD 2.7B
EquityUSD 563.5M
CashUSD 174.6M
Gross debtUSD 1.1B
Net debtUSD 878.2M
Current ratio0.98×
Net debt stands at 156% of equity.
History
5 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
Revenue $B
2.7
2.7
2.8
2.8
3.1
Operating income $B
−0.9
−0.2
0.0
0.2
0.1
EBITDA $B
−0.8
−0.1
0.1
0.3
0.3
Income tax $B
0.0
−0.0
0.0
0.0
0.0
Net income $B
−1.0
−0.3
−0.0
0.2
0.1
EPS, diluted $
−10.81
−3.67
−0.29
2.09
1.10
Dividend / sh $
·
·
·
·
·
Payout %
·
·
·
·
·
ROE %
−102.4
−21.4
−1.0
5.6
3.0
Shares out B
0.09
0.09
0.09
0.00
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
12 of 12
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed